Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114984552 | 11498455 | 2 | F | 20090514 | 20160719 | 20150911 | 20160725 | EXP | US-TAKEDA-TPA2011A08758 | TAKEDA | 0.00 | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114984552 | 11498455 | 1 | PS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 30 MG, UNK | 21073 | 30 | MG | TABLET | |||||||
| 114984552 | 11498455 | 2 | SS | ACTOPLUS MET | METFORMIN HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 15 MG - 850 MG, UNK | 0 | TABLET | |||||||||
| 114984552 | 11498455 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 850 MG, BID | U | 0 | 850 | MG | BID | |||||||
| 114984552 | 11498455 | 4 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | 850 MG, BID | U | 0 | 850 | MG | BID | |||||||
| 114984552 | 11498455 | 5 | C | HUMALOG | INSULIN LISPRO | 1 | UNK | U | 0 | ||||||||||
| 114984552 | 11498455 | 6 | C | DIABETA | GLYBURIDE | 1 | 5 MG, QD | U | 0 | 5 | MG | QD | |||||||
| 114984552 | 11498455 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | 25 MG, QD | U | 0 | 25 | MG | QD | |||||||
| 114984552 | 11498455 | 8 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 100 MG, QD | U | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114984552 | 11498455 | 1 | Type 2 diabetes mellitus |
| 114984552 | 11498455 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114984552 | 11498455 | OT |
| 114984552 | 11498455 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114984552 | 11498455 | Bladder transitional cell carcinoma | |
| 114984552 | 11498455 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114984552 | 11498455 | 1 | 20110520 | 20120520 | 0 | |
| 114984552 | 11498455 | 2 | 20070430 | 20091214 | 0 | |
| 114984552 | 11498455 | 3 | 2007 | 0 | ||
| 114984552 | 11498455 | 4 | 2007 | 0 | ||
| 114984552 | 11498455 | 5 | 201410 | 0 | ||
| 114984552 | 11498455 | 6 | 2007 | 201410 | 0 | |
| 114984552 | 11498455 | 7 | 201410 | 0 | ||
| 114984552 | 11498455 | 8 | 2011 | 2014 | 0 |